AGENDA
Welcome & Introductions
8:00 AM - 8:15 AM CT
Chris Prakash, MD
Director, Quality Services - Texas Oncology
Chair, Medical Oncology Quality - Texas Oncology
Past President, Texas Society of Clinical Oncology
Medical Director, Texas Oncology - Paris
Paris, TX
Clinical Updates in Myelofibrosis: Improving Equitable Care of Patients in Rural and Underserved Communities
8:15 AM - 8:45 AM CT | 0.5 CME/CE
Rami S. Komrokji, MD
Vice Chair, Department of Malignant Hematology
Section Head, Leukemia and MDS
Moffitt Cancer Center
Professor, Department of Oncologic Sciences
University of South Florida
Tampa, FL
Chris Prakash, MD
Director, Quality Services - Texas Oncology
Chair, Medical Oncology Quality - Texas Oncology
Past President, Texas Society of Clinical Oncology
Medical Director, Texas Oncology - Paris
Paris, TX
Evolving Treatment Approaches for Relapsed/Refractory Multiple Myeloma: Integrating the Latest Evidence Into the Care of Patients in Rural and Underserved Communities
8:45 AM - 9:45 AM CT | 1.0 CME/CE
Joshua R. Richter, MD, FACP
Associate Professor of Medicine
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
Director of Multiple Myeloma
Blavatnik Family Chelsea Medical Center
Mount Sinai Hospital
New York, NY
Chris Prakash, MD
Director, Quality Services - Texas Oncology
Chair, Medical Oncology Quality - Texas Oncology
Past President, Texas Society of Clinical Oncology
Medical Director, Texas Oncology - Paris
Paris, TX
Addressing Adverse Events Associated With Bispecific Antibody Therapies: Managing Care for Patients in Rural and Underserved Communities
9:45 AM - 10:45 AM CT | 1.0 CME/CE
Joshua R. Richter, MD, FACP
Associate Professor of Medicine
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
Director of Multiple Myeloma
Blavatnik Family Chelsea Medical Center
Mount Sinai Hospital
New York, NY
Chris Prakash, MD
Director, Quality Services - Texas Oncology
Chair, Medical Oncology Quality - Texas Oncology
Past President, Texas Society of Clinical Oncology
Medical Director, Texas Oncology - Paris
Paris, TX
Break
10:45 AM - 11:00 AM CT
From Conference to Community: ASCO 2025 Updates to Improve Breast Cancer Outcomes in Rural and Underserved Settings
11:00 AM - 12:00 PM CT | 1.0 CME/CE
Ian E. Krop, MD, PhD
Associate Cancer Center Director, Clinical Research
Professor of Medicine
Yale Cancer Center
Chief Scientific Officer, Translational Breast Cancer Research Consortium
New Haven, CT
Chris Prakash, MD
Director, Quality Services - Texas Oncology
Chair, Medical Oncology Quality - Texas Oncology
Past President, Texas Society of Clinical Oncology
Medical Director, Texas Oncology - Paris
Paris, TX
Advancing Equitable Prostate Cancer Care: Evidence-Based Strategies for Improving Outcomes in Rural and Underserved Communities
12:00 PM - 1:00 PM CT | 1.0 CME/CE
Alicia K. Morgans, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Director, Survivorship Program
Dana-Farber Cancer Institute
Boston, MA
Chris Prakash, MD
Director, Quality Services - Texas Oncology
Chair, Medical Oncology Quality - Texas Oncology
Past President, Texas Society of Clinical Oncology
Medical Director, Texas Oncology - Paris
Paris, TX
Agenda as of 6/12/25. Session order subject to change.